Cargando…
A novel self-microemulsifying formulation of paclitaxel for oral administration to patients with advanced cancer
To explore the parmacokinetics, safety and tolerability of paclitaxel after oral administration of SMEOF#3, a novel Self-Microemulsifying Oily Formulation, in combination with cyclosporin A (CsA) in patients with advanced cancer. Seven patients were enrolled and randomly assigned to receive oral pac...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360510/ https://www.ncbi.nlm.nih.gov/pubmed/16926835 http://dx.doi.org/10.1038/sj.bjc.6603312 |